Sign In
Buy ZBH
$84.98
+1.23 (+1.47%)
At Close: Jun 03, 2026
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results
02:22pm, Tuesday, 06'th May 2025
Zimmer Biomet Holdings, Inc ZBH reported better-than-expected earnings for the first quarter on Monday.
S&P 500 INDEX (SPX) Live: The Markets Turn Cautious in Data-Filled Week
12:05pm, Tuesday, 06'th May 2025
Live Updates Live Coverage Has Ended Markets Pivot to Ford Earnings 4:03 pm by Gerelyn Terzo The markets failed to turn around, ending the trading session lower across the board and ending a multi-ses
Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds
07:39am, Tuesday, 06'th May 2025
Zimmer Biomet's stock dropped nearly 10% on the back of soft Q1 results. Despite structural tailwinds, Zimmer Biomet's business is struggling in the face of high interest rates, trade tensions and com
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal
03:34pm, Monday, 05'th May 2025
Zimmer Biomet Holdings, Inc ZBH reported first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77.
ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket
02:00pm, Monday, 05'th May 2025
Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript
12:05pm, Monday, 05'th May 2025
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET Company Participants David DeMartino - SVP, IR Ivan Tornos - President & CEO Suketu Upadhyay - CFO & EV
Zimmer (ZBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
10:35am, Monday, 05'th May 2025
While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to
Zimmer Biomet (ZBH) Surpasses Q1 Earnings and Revenue Estimates
08:40am, Monday, 05'th May 2025
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.94 per share a year ago.
Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty
07:40am, Monday, 05'th May 2025
Zimmer Biomet Holdings on Monday lowered its full-year adjusted profit forecast, as the medical device maker anticipates a hit from its recent acquisition of Paragon 28 , currency volatility, and prop
Insights Into Zimmer (ZBH) Q1: Wall Street Projections for Key Metrics
10:21am, Wednesday, 30'th Apr 2025
Get a deeper insight into the potential performance of Zimmer (ZBH) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o
Zimmer Biomet to Report Q1 Earnings: Here's What to Expect
09:15am, Tuesday, 22'nd Apr 2025
ZBH's Hips business is expected to have witnessed growth on the back of its suite of navigation solutions in direct anterior stems and surgical impactors.
Zimmer Biomet Completes Acquisition of Paragon 28
09:00am, Monday, 21'st Apr 2025
Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. ("Zimmer Biomet"; NYSE and SIX: ZBH
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results
07:30am, Thursday, 10'th Apr 2025
WARSAW, Ind. , April 10, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Monday, May 5, 2025, at 8:3
ZBH Stock to Gain From Volume Growth Amid Rising Costs
01:15pm, Monday, 07'th Apr 2025
Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28,
